Related articles

Glutathione (GSH) is one of the body’s most important endogenous antioxidants,
often used as an intravenous adjunctive therapy in cancer patients to reduce oxidative stress, alleviate fatigue, and protect mitochondria, liver, and kidney function.
However, because cancer treatment is inherently complex, many patients and families worry: “Will supplementing glutathione ‘feed’ the tumour? Will it interfere with chemotherapy or radiotherapy?”

Hyperbaric oxygen therapy (HBOT) involves placing the patient in a chamber with 2–3 atmospheres of pure oxygen, dramatically increasing oxygen levels in blood and tissues.
In cancer care, it is not a primary treatment for the tumour itself but serves as a valuable supportive therapy to alleviate side effects, improve quality of life, and in some cases enhance treatment effectiveness.

Many people believe palliative supportive care is only for late-stage patients, but in reality, it can play a valuable role from the moment of diagnosis, throughout treatment, and into recovery.
Palliative supportive care is not “giving up on active treatment” — it runs alongside chemotherapy, radiotherapy, targeted therapy, or immunotherapy as a gentle ally.
Its simple goal: manage pain, side effects, and emotional burden so you can focus your energy on fighting the disease rather than battling discomfort.

After cancer treatment ends, many patients find that “appetite just doesn’t come back”:
food looks unappealing, a few bites feel filling, or even the smell triggers nausea.
This is not due to “lack of effort” — it is the result of treatment affecting multiple body systems and temporarily disrupting appetite regulation.
Understanding these common causes can reduce self-blame and open the door to more targeted ways to improve.

Walking through this valley together with the gentlest care
When a family member is diagnosed with cancer, you may notice they no longer laugh as easily, talk less, sleep poorly, or sometimes fall silent or tear up unexpectedly.
These low moods are completely normal — they are not only facing the illness itself, but also the uncertainty, loss of control, and guilt towards family.
As a caregiver, your role is not to “force them to cheer up”, but to let them know: their feelings are seen, accepted, and allowed to exist.

Cancer-related fatigue (CRF) after chemotherapy is experienced by more than 70–90 % of patients.
It is not ordinary tiredness — sleeping more does not fully resolve it, because it involves disrupted mitochondrial function, high oxidative stress, persistent low-grade inflammation, nutrient depletion, and hormonal changes working together.